FIELD: pharmaceuticals.
SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents a combined method of treating, which involves administering a composition which includes inositol phosphate and / or a pharmaceutically acceptable salt thereof; and dialysis fluid used separately, simultaneously or sequentially for treating or preventing pathological processes associated with disturbed regulation of physiologically adequate levels of inositol phosphate and / or its salts in blood plasma of a person undergoing dialysis. After the introduction of the improved composition of the dialysis fluid concentration of inositol phosphates in the blood serum is not significantly reduced.
EFFECT: disclosed is a combined method of treatment.
11 cl, 4 dwg, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION, CONTAINING CRYSTALLISATION-INHIBITING SUBSTANCES | 2009 |
|
RU2535094C2 |
| SOLUTION FOR BICARBONATE HEMODIALISYS | 2012 |
|
RU2521361C2 |
| METHOD OF PREPARING DIALYSIS FLUID | 2010 |
|
RU2425684C1 |
| METHOD FOR PREPARING ACIDIC COMPONENT FOR HYDROCARBONATE HEMODIALYSIS | 2006 |
|
RU2311202C1 |
| CONCENTRATED ACIDIC COMPONENT, KIT FOR PRODUCING IT, CONCENTRATED SOLUTION OF ACIDIC COMPONENT FOR PRODUCING HEMODIALYSIS SOLUTION AND METHOD FOR PRODUCING IT | 2013 |
|
RU2536994C1 |
| METHOD OF OBTAINING HEMODIALYSING SOLUTION FOR BICARBONATE HEMODIALYSIS | 2010 |
|
RU2435567C2 |
| METHOD FOR PRODUCING BICARBONATE DIALYSIS FLUID | 2009 |
|
RU2410080C1 |
| METHOD FOR TREATING THE CASES OF RENAL INSUFFICIENCY | 1998 |
|
RU2154499C2 |
| METHOD FOR ASSESSING EFFECTIVENESS OF DIALYSIS THERAPY ACCOMPANYING DETOXIFICATION | 2014 |
|
RU2569755C1 |
| USE OF DERIVATIVES CONTAINING THE C-O-P BONDS IN THE PATIENTS WITH RENAL INSUFFICIENCY | 2014 |
|
RU2725626C2 |
